An odd but synergistic couple: Immunotherapy combined with radiotherapy


Journal Article (Review)

In summary, there is considerable promise for combinations of immunotherapy with radiotherapy, but clinical experience is still limited. Preclinical models with greater relevance to human tumors should be used to continue identifying the best combinations and timing of radiation therapy and immunotherapy, but of course, only clinical trials will establish the true value of these combinations. Because we are entering an era with numerous therapies for cancer, all of which might act synergistically, the importance of patient selection is paramount. Predictive factors that indicate which patients are most likely to benefit from immunotherapy or radiation therapy are critically needed.

Duke Authors

Cited Authors

  • Morse, MA; Willett, CG

Published Date

  • August 1, 2008

Published In

Volume / Issue

  • 22 / 9

Start / End Page

  • 1075 - 1080

International Standard Serial Number (ISSN)

  • 0890-9091

Citation Source

  • Scopus